Navitus 2022 Drug Trend Report

   Its been many years since I posted news of a PBM Drug Trend Report. Once upon a time, PBM drug trend reports contained lots of interesting information. However, over time (in 2021, for example, when reports from the preceding year were published), CVS Caremark published only a bare-bones summary, while Prime Therapeutics, MedImpact, and other large PBMs all completelystopped publishing drug trend reports. The reason is basically because its becoming harder and harder for PBMs to present themselves as saving money when the biggest PBMs aren ' t saving any entities any money on prescription drugs anymore (I know, that ' s a lot of " ANY ' s " !); instead they are now largely stealing money manufacturers intend to be used in order to lower drug prices and instead they keep most of that money for their corporate parents. In 2021, Pembroke Consulting ' s Adam J. Fein covered a new dearth of information and the decline in drug trend reports athttps://www.drugchannels.net/2021/07/pbms-and-drug-spending-in-2020-data.html and that ' s worth checking out.That said, there are still a handful of drug trend reports from smaller PBMs such as Navitus Health Solutions. Navitus is a smaller PBM with about 7 million covered lives, of which 2.5 million are commercial lives. Navitus Health Solutions is jointly owned by SSM Health, a not-for-profit health system [which has 65% ownership stake in Navitus], and the retailer Costco Wholesale [which has a 35% ownership stake in Navi...
Source: Scott's Web Log - Category: Endocrinology Tags: 2022 2023 Drug Trend Report Navitus Navitus Health Solutions PBM Source Type: blogs